Daiwa Securities Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Daiwa Securities Group’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-413	Closed	-$7K	–	1210
2025 Q4	$7K	Hold	413	–	–	﹤0.01%	1206
2025 Q3	$5K	Sell	413 -115	-22%	-$1.26K	﹤0.01%	1196
2025 Q2	$4K	Hold	528	–	–	﹤0.01%	1163
2025 Q1	$4K	Hold	528	–	–	﹤0.01%	1141
2024 Q4	$5K	Hold	528	–	–	﹤0.01%	1160
2024 Q3	$4K	Hold	528	–	–	﹤0.01%	1176
2024 Q2	$3K	Hold	528	–	–	﹤0.01%	1224
2024 Q1	$3K	Hold	528	–	–	﹤0.01%	1232
2023 Q4	$5K	Hold	528	–	–	﹤0.01%	1202
2023 Q3	$4K	Hold	528	–	–	﹤0.01%	1170
2023 Q2	$5K	Hold	528	–	–	﹤0.01%	1175
2023 Q1	$6K	Hold	528	–	–	﹤0.01%	1136
2022 Q4	$2K	Hold	528	–	–	﹤0.01%	1212
2022 Q3	$4K	Hold	528	–	–	﹤0.01%	1171
2022 Q2	$5K	Buy	528 +150	+40%	+$1.68K	﹤0.01%	1167
2022 Q1	$5K	Hold	378	–	–	﹤0.01%	1170
2021 Q4	$9K	Sell	378 -62	-14%	-$1.47K	﹤0.01%	1153
2021 Q3	$10K	Buy	440 +202	+85%	+$3.21K	﹤0.01%	1138
2021 Q2	$3K	Hold	238	–	–	﹤0.01%	1105
2021 Q1	$3K	Hold	238	–	–	﹤0.01%	1099
2020 Q4	$3K	Sell	238 -404	-63%	-$5.88K	﹤0.01%	1080
2020 Q3	$9K	Buy	642 +46	+8%	+$666	﹤0.01%	1042
2020 Q2	$9K	Hold	596	–	–	﹤0.01%	1073
2020 Q1	$9K	Buy	596 +64	+12%	+$1.13K	﹤0.01%	1064
2019 Q4	$11K	Sell	532 -45	-8%	-$415	﹤0.01%	1052
2019 Q3	$3K	Hold	577	–	–	﹤0.01%	1101
2019 Q2	$4K	Buy	577 +113	+24%	+$720	﹤0.01%	1114
2019 Q1	$3K	Hold	464	–	–	﹤0.01%	1103
2018 Q4	$3K	Hold	464	–	–	﹤0.01%	1086
2018 Q3	$3K	Hold	464	–	–	﹤0.01%	1101
2018 Q2	$3K	Hold	464	–	–	﹤0.01%	1119
2018 Q1	$2K	Buy	+464	New	+$2.48K	﹤0.01%	1118

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Daiwa Securities Group's AUPH Position: Q1 2026 in Review

Daiwa Securities Group sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2026, closing a stake of 413 shares — an estimated $7K sold.

Daiwa Securities Group first reported a position in AUPH in Q1 2018 and held it in 32 quarters. The position peaked at $11K in Q4 2019. 260 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

Daiwa Securities Group reported no remaining Aurinia Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 413 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $7K.
Daiwa Securities Group first reported a position in Aurinia Pharmaceuticals in Q1 2018 and held it in 32 quarters.
Daiwa Securities Group's Aurinia Pharmaceuticals position peaked at $11K in Q4 2019.
260 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.